Skip to content
10-Q

Quarterly Report

Cellcyte Genetics Corp.

0001056520-13-000196

← back to feed
Filed
Aug 19, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2013 · Aug 19, 2013 82.33M sh
Operating Cash Flow Q2 2013 · Jun 30, 2013 −$6.04M
Operating Cash Flow Q2 2013 · Jun 30, 2012 −$28.51K
Cash And Equivalents Q2 2013 · Jun 30, 2013 −$31.86K
Stockholders Equity Q2 2013 · Jun 30, 2013 −$739.85K
Stockholders Equity Q2 2013 · Dec 31, 2012 −$655.76K
Current Liabilities Q2 2013 · Jun 30, 2013 $405.46K
Current Liabilities Q2 2013 · Dec 31, 2012 $334.97K
Total Liabilities Q2 2013 · Jun 30, 2013 $777.43K
Total Liabilities Q2 2013 · Dec 31, 2012 $681.38K
Current Assets Q2 2013 · Jun 30, 2013 $25.11K
Current Assets Q2 2013 · Dec 31, 2012 $9.4K
Total Assets Q2 2013 · Jun 30, 2013 $37.58K
Total Assets Q2 2013 · Dec 31, 2012 $25.62K
Eps Diluted Q2 2013 · Jun 30, 2013 $0.00
Eps Diluted Q2 2013 · Jun 30, 2013 $0.00
Eps Diluted Q2 2013 · Jun 30, 2012 $0.00
Eps Diluted Q2 2013 · Jun 30, 2012 $0.00
Eps Basic Q2 2013 · Jun 30, 2013 $0.00
Eps Basic Q2 2013 · Jun 30, 2013 $0.00
Eps Basic Q2 2013 · Jun 30, 2012 $0.00
Eps Basic Q2 2013 · Jun 30, 2012 $0.00
Sga Expense Q2 2013 · Jun 30, 2013 $2.63M
Sga Expense Q2 2013 · Jun 30, 2012 $18.22K
Sga Expense Q2 2013 · Jun 30, 2012 $33.81K
Rd Expense Q2 2013 · Jun 30, 2013 $1.3M
Net Income Q2 2013 · Jun 30, 2013 −$12.61M
Net Income Q2 2013 · Jun 30, 2012 $94.73K
Shares Diluted Q2 2013 · Jun 30, 2012 93.12M sh
Shares Diluted Q2 2013 · Jun 30, 2012 91.91M sh